US EditionPublished • loading... • Updated
Pfizer Mexico Plans to Increase Its Investment in Clinical Research to 10 Mdd per Year by 2030
Summary by El Economista
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Toluca, Edomex. The U.S. pharmaceutical company Pfizer plans to increase its annual investment in clinical research by between $5 and $10 million, as well as to double the impact of its innovations on patients by 2030, as part of its commitments to support Plan Mexico. “We have an internal focus on increasing clinical studies to attract greater investment and that the studies that are put around the world have greater representativeness in Mexic…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
